NEW YORK (GenomeWeb News) - Serologicals shareholders have approved Millipore's buyout offer, Serologicals said today.
 
GenomeWeb News on April 25 reported Millipore's plan to acquire Serologicals for $1.4 billion. The shareholders will receive $31.55 per share in cash.
 
About 82 percent of shares outstanding voted in favor of the deal, the Atlanta-based company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more